4-Chloro-3-pyridinesulfonamide (CAS 33263-43-3): A Key Pharmaceutical Intermediate

Discover the critical role of this specialized compound in advanced pharmaceutical synthesis and drug development.

Get a Quote & Sample

Key Advantages

High Purity and Quality

With a purity of at least 98%, this compound guarantees reliable outcomes in your organic synthesis processes, minimizing side reactions and ensuring product integrity for pharmaceutical intermediate applications.

Versatile Reactivity

Its chemical structure allows for diverse reactions, making it an excellent starting material for creating a wide array of heterocyclic pyridine-3-sulfonamide derivatives with targeted biological activities.

Established Pharmaceutical Role

Its documented use in the synthesis of Cefozopran and as a precursor for carbonic anhydrase inhibitors highlights its established importance in drug development and manufacturing.

Key Applications

Pharmaceutical Synthesis

Serves as a critical building block for a wide range of pharmaceutical intermediates and active pharmaceutical ingredients (APIs).

Carbonic Anhydrase Inhibition Research

Essential in creating compounds that target carbonic anhydrase isoforms, with potential applications in treating glaucoma, epilepsy, and certain cancers.

Antibiotic Development

A key intermediate in the synthesis of important antibiotics such as Cefozopran, contributing to the development of effective treatments for bacterial infections.

Heterocyclic Chemistry

Facilitates the synthesis of complex heterocyclic structures, enabling innovation in medicinal chemistry and material science.